Pontifax
VC
2004
$1 200 M
Herzliya, Tel Aviv District, Israel
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with $1.2 billion under management.
We seek transformative, cutting-edge life sciences technologies at all development stages. Our portfolio comprises of about 100 companies that develop breakthrough solutions to substantial unmet needs.
INVESTING IN BREAKTHROUGH
INNOVATIONS ONLY
Pontifax invests in breakthrough innovation regardless of therapeutic area or development stage. We establish our own companies as well as partner with existing management to nurture start-ups to maturity. Pontifax takes a hands-on approach in its portfolio management and is deeply involved in charting the course of each company.
Industry
Region of investment
Pontifax Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Pontifax AgTech
|
Venture Capital (VC)
|
Agriculture
Biotechnology
Financial Services
Foodtech
Software
|
Seed
Series A
Series B
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$40 M
|
December 2015
|
|
Pontifax IV
|
Venture Capital (VC)
|
Agriculture
Biotechnology
Financial Services
Robotics
Software
|
Pre-seed
Seed
Series A
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$150 M
|
December 2015
|
|
Pontifax V
|
Venture Capital (VC)
|
Agriculture
Biotechnology
Financial Services
Foodtech
Robotics
|
Pre-seed
Seed
Series A
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$240 M
|
January 2018
|
